Compare OSBC & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OSBC | INMD |
|---|---|---|
| Founded | 1981 | 2008 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 842.0M |
| IPO Year | 2014 | 2018 |
| Metric | OSBC | INMD |
|---|---|---|
| Price | $19.45 | $13.58 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 4 | 6 |
| Target Price | ★ $22.63 | $16.75 |
| AVG Volume (30 Days) | 302.0K | ★ 818.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 1.43% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.62 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $25.15 | $1.70 |
| Revenue Next Year | $3.21 | $3.99 |
| P/E Ratio | $12.07 | ★ $10.11 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.21 | $12.72 |
| 52 Week High | $22.00 | $19.09 |
| Indicator | OSBC | INMD |
|---|---|---|
| Relative Strength Index (RSI) | 41.87 | 45.21 |
| Support Level | $19.20 | $13.28 |
| Resistance Level | $21.33 | $14.80 |
| Average True Range (ATR) | 0.59 | 0.28 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 29.11 | 58.85 |
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company has one operating segment, which is community banking. The company's revenue consists of interest, commission, payments, and other income.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.